相似文献
1
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
J Clin Microbiol. 1986 Aug;24(2):269-71. doi: 10.1128/jcm.24.2.269-271.1986.
2
In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
Mycopathologia. 1984 Apr 30;86(1):45-50. doi: 10.1007/BF00437228.
3
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Mycopathologia. 1986 Apr;94(1):27-30. doi: 10.1007/BF00437258.
4
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
J Clin Microbiol. 1986 Oct;24(4):507-11. doi: 10.1128/jcm.24.4.507-511.1986.
5
Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
J Antimicrob Chemother. 1996 Feb;37(2):265-73. doi: 10.1093/jac/37.2.265.
6
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
J Chemother. 1991 Jun;3(3):139-42. doi: 10.1080/1120009x.1991.11739080.
7
Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
J Antimicrob Chemother. 1998 Oct;42(4):439-44. doi: 10.1093/jac/42.4.439.
8
Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
Mycopathologia. 1989 Apr;106(1):31-4. doi: 10.1007/BF00436923.
9
In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.
Antimicrob Agents Chemother. 1999 May;43(5):1258-9. doi: 10.1128/AAC.43.5.1258.
10
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Chemotherapy. 1991;37(1):23-31. doi: 10.1159/000238828.
引用本文的文献
1
Standardisation of high throughput microdilution antifungal susceptibility testing for Candida albicans and Cryptococcus neoformans.
Sci Rep. 2024 Oct 8;14(1):23407. doi: 10.1038/s41598-024-74068-2.
2
The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing.
J Fungi (Basel). 2023 Sep 27;9(10):973. doi: 10.3390/jof9100973.
3
Analysis of growth characteristics of filamentous fungi in different nutrient media.
J Clin Microbiol. 2001 Feb;39(2):478-84. doi: 10.1128/JCM.39.2.478-484.2001.
4
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies.
J Clin Microbiol. 1998 Oct;36(10):2817-22. doi: 10.1128/JCM.36.10.2817-2822.1998.
5
Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.
J Clin Microbiol. 1993 May;31(5):1370-2. doi: 10.1128/jcm.31.5.1370-1372.1993.
6
Entry of five antifungal agents into the ovine lung.
Antimicrob Agents Chemother. 1987 Aug;31(8):1234-7. doi: 10.1128/AAC.31.8.1234.
7
Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.
J Clin Microbiol. 1988 Nov;26(11):2307-12. doi: 10.1128/jcm.26.11.2307-2312.1988.
8
Overview of medically important antifungal azole derivatives.
Clin Microbiol Rev. 1988 Apr;1(2):187-217. doi: 10.1128/CMR.1.2.187.
9
Improved method for azole antifungal susceptibility testing.
J Clin Microbiol. 1988 Sep;26(9):1874-7. doi: 10.1128/jcm.26.9.1874-1877.1988.
10
In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.
Antimicrob Agents Chemother. 1992 Apr;36(4):898-901. doi: 10.1128/AAC.36.4.898.
本文引用的文献
1
Culture of the urine.
J Lab Clin Med. 1960 Dec;56:899-907.
2
[Clinical and experimental studies on antimycotics].
Arzneimittelforschung. 1953 Jun;3(6):267-76.
3
Chemotherapy of the systemic mycoses.
Med Clin North Am. 1982 Jan;66(1):221-33. doi: 10.1016/s0025-7125(16)31455-9.
4
In vitro activities of two new antifungal azoles.
Antimicrob Agents Chemother. 1984 Mar;25(3):339-41. doi: 10.1128/AAC.25.3.339.
5
Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media.
Antimicrob Agents Chemother. 1984 Sep;26(3):364-7. doi: 10.1128/AAC.26.3.364.
6
Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.
Antimicrob Agents Chemother. 1984 Mar;25(3):316-8. doi: 10.1128/AAC.25.3.316.
7
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
J Clin Microbiol. 1984 Mar;19(3):412-6. doi: 10.1128/jcm.19.3.412-416.1984.
8
Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species.
J Antimicrob Chemother. 1983 Apr;11(4):381-3. doi: 10.1093/jac/11.4.381.
9
In vitro studies with 5-fluorocytosine.
Appl Microbiol. 1969 Jun;17(6):871-7. doi: 10.1128/am.17.6.871-877.1969.
10
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
J Infect Dis. 1976 Oct;134(4):336-41. doi: 10.1093/infdis/134.4.336.
Zotero 插件